loadpatents
name:-0.016354084014893
name:-0.014355897903442
name:-0.0016770362854004
Kurumatani; Hajimu Patent Filings

Kurumatani; Hajimu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kurumatani; Hajimu.The latest application filed is for "hemostatic material".

Company Profile
1.14.15
  • Kurumatani; Hajimu - Tokyo-to JP
  • Kurumatani; Hajimu - Kanagawa JP
  • Kurumatani; Hajimu - Tokyo JP
  • Kurumatani; Hajimu - Fujisawa JP
  • Kurumatani; Hajimu - Kamakura N/A JP
  • Kurumatani; Hajimu - Kamakura-shi JP
  • Kurumatani; Hajimu - Fujisawa-Shi JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Hemostatic Material
App 20220096707 - Takeoka; Shinji ;   et al.
2022-03-31
Carboxylic Acid-type Lipid, And Lipid Particle And Lipid Membrane Each Comprising Carboxylic Acid-type Lipid
App 20210387943 - Takeoka; Shinji ;   et al.
2021-12-16
Fortifier
Grant 10,149,909 - Kurumatani , et al. Dec
2018-12-11
Method of ameliorating uremia
Grant 9,913,825 - Takenaka , et al. March 13, 2
2018-03-13
Therapeutic agent and treatment method for ameliorating uremia
Grant 9,783,518 - Takenaka , et al. October 10, 2
2017-10-10
Method Of Ameliorating Uremia
App 20170224652 - Takenaka; Masahiko ;   et al.
2017-08-10
Fortifier
App 20170080089 - Kurumatani; Hajimu ;   et al.
2017-03-23
Combination therapy for the treatment of chronic renal failure with an angiotensin II receptor antagonist and beraprost
Grant 9,546,145 - Kurumatani , et al. January 17, 2
2017-01-17
Therapeutic agent for renal failure
Grant 9,457,032 - Kurumatani , et al. October 4, 2
2016-10-04
Therapeutic agent for chronic renal failure
Grant 8,575,175 - Matsuda , et al. November 5, 2
2013-11-05
Therapeutic Agent For Chronic Renal Failure
App 20110178103 - Matsuda; Fuko ;   et al.
2011-07-21
Fortifier
App 20090176848 - Kurumatani; Hajimu ;   et al.
2009-07-09
Therapeutic Agent For Renal Failure
App 20090163584 - Kurumatani; Hajimu ;   et al.
2009-06-25
Therapeutic Agent and Treatment Method for Ameliorating Uremia
App 20090143463 - Takenaka; Masahiko ;   et al.
2009-06-04
Remedy Or Preventive For Kidney Disease And Method Of Diagnosing Kidney Disease
App 20080269155 - Yamada; Masateru ;   et al.
2008-10-30
Remedy or preventive for kidney disease and method of diagnosing kidney disease
App 20060293256 - Yamada; Masateru ;   et al.
2006-12-28
Fortifier
App 20060217421 - Kurumatani; Hajimu ;   et al.
2006-09-28
Therapeutic agent for renal failure
App 20060106095 - Kurumatani; Hajimu ;   et al.
2006-05-18
C-C chemokine synthesis inhibitor
Grant 6,653,345 - Kurumatani , et al. November 25, 2
2003-11-25
Therapeutic agent for renal failure
App 20030092760 - Kurumatani, Hajimu ;   et al.
2003-05-15
Pericyte protective agent
App 20030013898 - Yamamoto, Hiroshi ;   et al.
2003-01-16
C-C chemokine synthesis inhibitor
App 20020193427 - Kurumatani, Hajimu ;   et al.
2002-12-19
Method of treatment for diabetic neuropathy
Grant 5,981,594 - Okamoto , et al. November 9, 1
1999-11-09
Implantation materials
Grant 5,632,776 - Kurumatani , et al. May 27, 1
1997-05-27
Physiologically-active substance fixed to a thin fiber carrier with an alkylene oxide chain
Grant 5,043,278 - Nagaoka , et al. August 27, 1
1991-08-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed